MiCAN Technologies is a company that develops and sells infectious disease research and drug discovery tools by utilizing regenerative medicine technology using ES and iPS cells. It provides immature red blood-like cells for Malaria (P.vivax) research and special myeloid lineage cells for Dengue and other infectious diseases.